Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Furthermore, the study suggests that this combination of drugs may help to reduce both liver involvement and associated cardiovascular complications. These results open the door to the development of ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study from Karolinska Institutet published in Alzheimer's & Dementia: The Journal of the Alzheimer's ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Cardiovascular Biologics Market Is Expected To Reach US$ 4.23 Billion By 2033 Datam Intelligence. EINPresswire/ -- Market Overview: The Cardiovascular Biologics Market represents a rapidly evolving ...

Rheumatoid arthritis (RA) disease activity and inflammatory markers are associated with major adverse cardiovascular events (MACEs) in biologic disease-modifying antirheumatic drug (bDMARD) nonusers ...

Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk-screening and stratification is advised for IBD patients before JAK inhibitor or S1P ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...